SCHEMBL4332920

SCHEMBL4332920

CCOCCNC(=O)c1ccc2[nH]nc(-c3cc4ccccc4s3)c2c1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 1/20 0.42
JAK3 P52333 1/20 0.42
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
KMT2A Q03164 2/20 0.37
PPARG P37231 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
NR2E3 Q9Y5X4 1/20 0.37
NCOR2 Q9Y618 1/20 0.37
MAPK10 P53779 1/20 0.37
ACLY P53396 1/20 0.36
RAB9A P51151 2/20 0.36
DRD3 P35462 3/20 0.36
DRD2 P14416 2/20 0.36
DRD1 P21728 2/20 0.36
TNIK Q9UKE5 2/20 0.36
HTR1A P08908 1/20 0.36
DRD4 P21917 1/20 0.36
ADRA1D P25100 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4334929 0.87 LMNA (0.41) JAK2JAK3MAPK10RAB9ADRD3
SCHEMBL13198254 0.87 DRD2 (0.40) JAK2JAK3MAPK10RAB9ADRD3
SCHEMBL4335810 0.85 JAK2 (0.39) JAK2JAK3KMT2AMAPK10RAB9A
SCHEMBL4339889 0.84 BRD4 (0.46) JAK2JAK3ALDH1A1HPGDMAPK10
SCHEMBL2865451 0.84 MAPK10 (0.42) JAK2JAK3MAPK10DRD2DRD4
SCHEMBL4331810 0.83 KDR (0.42) JAK2JAK3KDM4EALDH1A1HPGD
SCHEMBL4329228 0.83 HPGD (0.44) JAK2JAK3KDM4EALDH1A1HPGD
SCHEMBL4334979 0.83 MAPT (0.44) KDM4EALDH1A1HPGDKMT2AMAPK10
SCHEMBL2861021 0.82 PIP5K1C (0.46) JAK2JAK3KMT2AMAPK10RAB9A
SCHEMBL4332224 0.82 MAPT (0.46) KDM4EALDH1A1HPGDKMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 JAK2 145/4885JAK3 776/4885KDM4E 2531/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 JAK2 145/4885JAK3 776/4885KDM4E 2531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.